CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award See remarks acquired 161,818 shares (grant or award)
- 4/A Open-market sale See remarks sold 1,657 shares at $11.16 ($18,492)
- 4/A Open-market sale Chief Financial Officer sold 2,012 shares at $11.16 ($22,454)
- 4/A Open-market sale President, R&D sold 2,850 shares at $11.16 ($31,806)
- 4/A Open-market sale Chief Legal Officer sold 1,936 shares at $11.16 ($21,606)
- 4 Gift Director gave 12,099 shares (gift)
- 4 Open-market sale See remarks sold 739 shares at $11.16 ($8,247)
- 4 Open-market sale Chief Financial Officer sold 863 shares at $11.16 ($9,631)
- 4 Open-market sale President, R&D sold 1,383 shares at $11.16 ($15,434)
- 4 Open-market sale Chief Legal Officer sold 863 shares at $11.16 ($9,631)
- 4 Open-market sale See remarks sold 297 shares at $15.36 ($4,562)
- 4 Open-market sale Chief Financial Officer sold 347 shares at $15.36 ($5,330)
- 4 Open-market sale President, R&D sold 763 shares at $15.36 ($11,720)
- 4 Open-market sale Chief Legal Officer sold 347 shares at $15.36 ($5,330)
- 4 Open-market sale President and CEO sold 42,000 shares at an average $20.99 ($881,720)
- 4 Open-market sale See remarks sold 740 shares at $21.56 ($15,954)
- 5 Insider Annual Insider Trading Report
Page 9 of 16 · 320 filings